MyFinsight
Home
Blog
About
Contact
Proceeds from issuance of
common stock and...
$164,089K
Proceeds from sales of
common stock, pursuant...
$290K
Net cash provided by
financing activities
$164,364K
Canceled cashflow
$15K
Net increase
(decrease) in cash and cash...
$23,343K
Canceled cashflow
$141,021K
Repayment of note payable
$15K
Maturities of
available-for-sale securities
$47,641K
Share-based compensation
$2,553K
Depreciation and
amortization expense
$1,126K
Other noncash income,
net
-$78K
Other noncurrent
liabilities
$51K
Net cash used in
investing activities
-$109,553K
Net cash used in
operating activities
-$31,468K
Canceled cashflow
$47,641K
Canceled cashflow
$3,808K
Purchases of
available-for-sale securities
$150,336K
Net loss
-$26,189K
Accounts payable and
accrued expenses
-$4,213K
Accrued personnel
expenses
-$3,613K
Additions to property and
equipment
$6,858K
Net accretion of
discounts on...
-$490K
Interest receivable
$392K
Prepaid expenses and
other current assets
$327K
Accounts receivable
$52K
Back
Back
Cash Flow
Perspective Therapeutics, Inc. (CATX)
Perspective Therapeutics, Inc. (CATX)
source: myfinsight.com